case_images: PMC4007744_01
case_images: ASD secundum (A) and Cor triatriatum sinister with fenestration (f).
case_images: CRIM.CARDIOLOGY2011-740981.002.jpg
case_images: PMC4007744_01_CRIM.CARDIOLOGY2011-740981.002.jpg
case_images: fig2
case_images: Occlutech Figulla device was deployed.
case_images: CRIM.CARDIOLOGY2011-740981.003.jpg
case_images: PMC4007744_01_CRIM.CARDIOLOGY2011-740981.003.jpg
case_images: fig3
case_images: Device was deployed. (Figure 3) TEE revealed proper site of device without obstruction, no residual shunt, and residual fenestration of cor triatriatum membrane was 12 mm.
case_images: TEE after procedure demonstrate no obstruction blood flow through fenestration of cor triatriatum membrane (f).
case_images: CRIM.CARDIOLOGY2011-740981.004.jpg
case_images: PMC4007744_01_CRIM.CARDIOLOGY2011-740981.004.jpg
case_images: fig4
case_images: We used TEE to recheck that the device will not occlude pulmonary venous return, and TEE revealed no turbulence flow of pulmonary veins and no turbulence flow of blood flow through fenestration of cor triatriatum membrane (Figure 4).
case_images: After releasing the device.
case_images: CRIM.CARDIOLOGY2011-740981.005.jpg
case_images: PMC4007744_01_CRIM.CARDIOLOGY2011-740981.005.jpg
case_images: fig5
case_images: The device was released (Figure 5).